Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / clinical-evidence-gap-analysis.docx
clinical-evidence-gap-analysis.docx
Parties
HARKNESS LLP
Genome Dx Therapeutics Inc
Sable LLP
Dates
April 15, 2024
March 29, 2024
April 9, 2024
April 22, 2024
December 14, 2022
March 22, 2024
June 28, 2024
August 15, 2021
January 18, 2023
April 5, 2024
Amounts
$3,850
$20,290,500
$34,502,500
$28,500,000
$19,100,000
$1.5
$2.5
Obligations
The MolDx program has consistently emphasized that predictive biomarker tests must demonstrate a sufficiently low false-negative rate to ensure that patients are not inappropriately denied access to effective therapies
If protocol amendment is required to formalize sub-group analyses that were not originally pre-specified, the timeline would be longer and the analyses would carry less evidentiary weight